Endolymphatic Hydrops Asymmetry Can Distinguish Meniere Patients From Controls

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Feb. 5, 2024 -- Endolymphatic hydrops (EH) asymmetry can differentiate patients with Meniere disease (MD) from normal controls, according to a study published online Dec. 21 in Frontiers in Neurology.

Tae-Soo Noh, from the Seoul National University College of Medicine in South Korea, and colleagues examined the extent of hydrops in MD patients and age- and sex-matched normal controls to assess which outcome measure most effectively distinguishes between MD patients and controls. Magnetic resonance imaging (MRI) was performed using a 3-T MR platform; MR images covering an inner ear were 3D-stacked. The volumes of the endolymphatic and perilymphatic spaces were yielded on analyses of all images, including the vestibule or cochlea; the quantitative volumetric EH percentage was calculated as the endolymph volume (μL)/(endolymph+perilymph volume [μL]).

The researchers found that the EH percentage was significantly greater in ipsilateral versus contralateral MD ears and in ipsilateral MD ears versus control ears for the vestibule. The values for the cochlea showed a slightly higher EH percentage in ipsilateral MD ears, but did not significantly differ from that seen in contralateral or control ears. The EH asymmetries (right ear minus left ear EH percentage) were 12.0 ± 10.2 and 8.4 ± 8.6 percent in the vestibule and cochlea, respectively, in the MD group, which were significantly larger than those of controls.

"EH asymmetry effectively differentiates MD patients from normal controls," the authors write. "In our study, the sensitivity, specificity, and area under the curve of EH asymmetry were better than those of conventional EH percentage."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-02-06 00:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords